2018
DOI: 10.1016/j.canlet.2017.10.027
|View full text |Cite
|
Sign up to set email alerts
|

Krüppel-like factor 9 down-regulates matrix metalloproteinase 9 transcription and suppresses human breast cancer invasion

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
69
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 67 publications
(77 citation statements)
references
References 40 publications
4
69
0
Order By: Relevance
“…Salvador et al reported that LOXL2 was involved in the metastatic process via modifying the ECM stiffness in PyMT tumors. Evidence highlights a dominant role for MMP‐9 in breast cancer invasion as well . These results were in line with our findings that LOXL2 and MMP‐9 functioned as HIF‐2α targets and could mediate the ATP‐driven invasion process.…”
Section: Discussionsupporting
confidence: 91%
“…Salvador et al reported that LOXL2 was involved in the metastatic process via modifying the ECM stiffness in PyMT tumors. Evidence highlights a dominant role for MMP‐9 in breast cancer invasion as well . These results were in line with our findings that LOXL2 and MMP‐9 functioned as HIF‐2α targets and could mediate the ATP‐driven invasion process.…”
Section: Discussionsupporting
confidence: 91%
“…MMPs are abundantly detected in numerous malignant neoplasms and have critical implications in almost all stages of tumour progression [2]. Recent studies have shown that aberrant MMP expression is associated with the invasion and metastasis of several malignant tumours (colorectal [3], prostate [4], liver [5], breast [6], retinoblastoma [7], and lung [8]) both in vitro and vivo. Among the MMPs, MMP7 (aka matrilysin1) is the smallest secreted proteolytic enzyme, lacking the C-terminal hemopexin domain compared with other family members, with a wide spectrum of substrate specificity against ECM components, including laminin, type IV collagen, fibronectin, and proteoglycans [9,10], as well as other molecules, such as E-cadherin, β4 integrin, tumour necrosis factor-α, and the Fas ligand [11].…”
Section: Introductionmentioning
confidence: 99%
“…27,28 The promoter region of the MMP-9 gene contains the binding site of NF-kB; therefore, MMP-9 expression decreases when NF-kB is suppressed. 29,30 Also, some reports argue that NF-kB suppresses MMP-2 expression. 31e34 Few reports, however, focus on the molecular mechanisms between NF-kB and MMP-2.…”
Section: Discussionmentioning
confidence: 99%